Compare PRE & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRE | OCCI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.3M | 139.4M |
| IPO Year | N/A | N/A |
| Metric | PRE | OCCI |
|---|---|---|
| Price | $16.67 | $4.56 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 137.5K | 115.8K |
| Earning Date | 11-10-2025 | 12-11-2023 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,079,000.00 | N/A |
| Revenue This Year | $219.28 | N/A |
| Revenue Next Year | $124.38 | $10.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 201.54 | N/A |
| 52 Week Low | $3.10 | $5.47 |
| 52 Week High | $17.99 | $10.15 |
| Indicator | PRE | OCCI |
|---|---|---|
| Relative Strength Index (RSI) | 64.41 | 38.17 |
| Support Level | $14.02 | $4.50 |
| Resistance Level | $15.70 | $5.09 |
| Average True Range (ATR) | 1.18 | 0.13 |
| MACD | 0.19 | -0.03 |
| Stochastic Oscillator | 98.19 | 12.31 |
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.